Contact Us

DESTINATION NEWS

TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections

Oct 17, 2024

SUZHOU,China,Oct. 16,2024-- TenNor Therapeutics,a clinical stage company dedicated to developing new therapies to address unmet needs in infectious diseases,announced today the initial closing of a Se

Trina Storage powers Eku Energy in Completing its First Battery Storage Project in the UK

Oct 17, 2024

MUNICH,Oct. 16,2024-- Recently,Trina Storage,a global leader in energy storage solutions,announced the successful grid connection and commissioning of the Maldon 40MWh Battery Energy Storage System (B

Squirrel Ai Debuts S20 Tablet with TCL's Advanced Display and Pioneering Adaptive Learning Technology at CES

Oct 17, 2024

SHANGHAI,Oct. 16,2024-- TCL\'s NXTPAPER display has been integrated into the latest flagship smart learning tablet,the Squirrel Ai S20,which made its debut at CES 2024. The collaboration between TCL a

Moomoo Singapore Unveils ETF Robo-Advisory Service; Joins Hands with BlackRock to Offer ETF Model Portfolios

Oct 17, 2024

Brings five flagship ETF Model Portfolios,powered by BlackRock,to investors in Asia for the first time.

Uxin Announces Strategic Partnership with Wuhan City Economic & Technological Development Zone

Oct 17, 2024

BEIJING,Oct. 16,2024-- Uxin Limited ("Uxin" or the "Company",together with its subsidiaries,the "Group") (Nasdaq: UXIN),China\'s leading used car retailer,today announced

IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer

Oct 17, 2024

HONG KONG,Oct. 16,2024-- Akeso Biopharma (9926.HK) (" Akeso",the "Company" ) announced positive results in progression-free survival (PFS) and overall survival (OS) from its Phase

1 ... 282 283 284 285 286 287 288 ... 375